JPRN-UMIN000017117
Completed
Phase 1
Multicenter study of Matrix Metalloproteinase (MMP)-9 expression on meibomian gland dysfunction using dry eye diagnostic device "InflammaDry" - MMP-9 expression on meibomian gland dysfunction using dry eye diagnostic device InflammaDry
id and Meibomian Gland Working Group0 sites100 target enrollmentStarted: April 15, 2015Last updated:
ConditionsMeibomian gland dysfunction
Overview
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- id and Meibomian Gland Working Group
- Enrollment
- 100
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional,observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who may have the possibility of contagious diseases
Investigators
Similar Trials
Recruiting
Not Applicable
Treating shrinking of the lungs by an antibioticHealth Condition 1: null- Patients suffering from idiopathic pulmonary diseaseCTRI/2011/11/002108Institute of Pulmocare Research30
Completed
Not Applicable
Clinical evaluation of matrix metalloproteinases as early diagnostic markers of peritoneal deterioration and encapsulating peritoneal sclerosis.encapsulating peritoneal sclerosis (EPS)/ sclerosing encapsulating peritonitis(SEP)JPRN-UMIN000010572Division of Nephrology, Department of Medicine, Jichi Medical University400
Completed
Not Applicable
Case-control Study on Matrix Metalloproteinase Levels in Tissue in Patients With Keloid ScarKeloidNCT01125137Henry Ford Health System20
Recruiting
Not Applicable
Study of Matrix Metalloproteinase (MMP)-9 expressions in ocular surface disorders using dry eye diagnostic kit InflammaDryInfectious keratitis, non-infectious corneal ulcer, Sjogren syndrome, meibomian gland dysfunction, etc.JPRN-UMIN000014423Department of Ophthalmology, Nihon University School of Medicine30
Unknown
Early Phase 1
Matrix Metalloproteinases Neutralizing Agents in Oral Lichen PlanusOral Lichen PlanusNCT04336488Jaylane kadry Ghonima40